β-catenin interacts with and inhibits NF-κB in human colon and breast cancer

Cancer Cell

Volumn 2, Issue 4, 2002, Pages 323-334

  Deng, Jiong ^a   Miller, Stephanie A ^a   Wang, Hong Ying ^a   Xia, Weiya ^a   Wen, Yong ^a   Zhou, Binhua P ^a   Li, Yan ^a   Lin, Shiaw Yih ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; BETA GALACTOSIDASE; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; GLUTATHIONE TRANSFERASE; I KAPPA B; LUCIFERASE; PRIMER DNA; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA BINDING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TISSUE SECTION; TRANSACTIVATION; BREAST TUMOR; CELL CULTURE; CHEMISTRY; COLON TUMOR; DOWN REGULATION; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; IMMUNOLOGY; METABOLISM; OSTEOSARCOMA; PATHOLOGY; PROMOTER REGION; PROTEIN SYNTHESIS; SERODIAGNOSIS;

ANTIGENS, CD95; BETA CATENIN; BETA-GALACTOSIDASE; BREAST NEOPLASMS; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; DNA PRIMERS; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; HUMANS; I-KAPPA B PROTEINS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; LUCIFERASES; NF-KAPPA B; OSTEOSARCOMA; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036781671     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00154-X     Document Type: Article

References (52)

1. Baeuerle, P.A., and Baltimore, D. (1988). IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540-546.
2. Behrens, J., Jerchow, B.A., Wurtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kuhl, M., Wedlich, D., and Birchmeier, W. (1998). Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 280, 596-599.
3. Ben-Ze'ev, A., and Geiger, B. (1998). Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer. Curr. Opin. Cell Biol. 10, 629-639.
4. Bours, V., Bentires-Alj, M., Hellin, A.C., Viatour, P., Robe, P., Delhalle, S., Benoit, V., and Merville, M.P. (2000). Nuclear factor-κB, cancer, and apoptosis. Biochem. Pharmacol. 60, 1085-1089.
5. Butler, L.M., Hewett, P.J., Butler, W.J., and Cowled, P.A. (1998). Downregulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement. Br. J. Cancer 77, 1454-1459.
6. Chan, H., Bartos, D.P., and Owen-Schaub, L.B. (1999). Activation-dependent transcriptional regulation of the human Fas promoter requires NF-κB p50-p65 recruitment. Mol. Cell. Biol. 19, 2098-2108.
7. Chen, S., Guttridge, D.C., You, Z., Zhang, Z., Fribley, A., Mayo, M.W., Kitajewski, J., and Wang, C.Y. (2001). Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription. J. Cell Biol. 152, 87-96.
8. Cheng, G., and Meinkoth, J.L. (2001). Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells. Oncogene 20, 7334-7341.
9. Crawford, H.C., Fingleton, B.M., Rudolph-Owen, L.A., Goss, K.J., Rubinfeld, B., Polakis, P., and Matrisian, L.M. (1999). The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene 18, 2883-2891.
10. Damalas, A., Kahan, S., Shtutman, M., Ben-Ze'ev, A., and Oren, M. (2001). Deregulated β-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J. 20, 4912-4922.
11. Eischen, C.M., Roussel, M.F., Korsmeyer, S.J., and Cleveland, J.L. (2001). Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol. Cell. Biol. 21, 7653-7662.
12. Gapuzan, M.E., Yufit, P.V., and Gilmore, T.D. (2002). Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-κB have a malignantly transformed phenotype. Oncogene 21, 2484-2492.
13. Gerritsen, M.E., Williams, A.J., Neish, A.S., Moore, S., Shi, Y., and Collins, T. (1997). CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA 94, 2927-2932.
14. Ghosh, S., May, M.J., and Kopp, E.B. (1998). NF-κB and Rel proteins: evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
15. Gilmore, T.D., Koedood, M., Piffat, K.A., and White, D.W. (1996). Rel/NF-κB/IκB proteins and cancer. Oncogene 13, 1367-1378.
16. Gumbiner, B.M. (1995). Signal transduction of β-catenin. Curr. Opin. Cell Biol. 7, 634-640.
17. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B., and Kinzler, K.W. (1998). Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512.
18. Hecht, A., Vleminckx, K., Stemmler, M.P., van Roy, F., and Kemler, R. (2000). The p300/CBP acetyltransferases function as transcriptional coactivators of β-catenin in vertebrates. EMBO J. 19, 1839-1850.
19. Hoeflich, K.P., Luo, J., Rubie, E.A., Tsao, M.S., Jin, O., and Woodgett, J.R. (2000). Requirement for glycogen synthase kinase-3β in cell survival and NF-βB activation. Nature 406, 86-90.
20. Hsu, B., Marin, M.C., el-Naggar, A.K., Stephens, L.C., Brisbay, S., and McDonnell, T.J. (1995). Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene 11, 175-179.
21. Hunt, K.K., Deng, J., Liu, T.J., Wilson-Heiner, M., Swisher, S.G., Clayman, G., and Hung, M.C. (1997). Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res. 57, 4722-4726.
22. Kikuchi, A. (1999). Roles of Axin in the Wnt signalling pathway. Cell. Signal. 11, 777-788.
23. Kim, K., Pang, K.M., Evans, M., and Hay, E.D. (2000). Overexpression of β-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol. Biol. Cell 11, 3509-3523.
24. Kinzler, K.W., and Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87, 159-170.
25. Korinek, V., Barker, N., Morin, P.J., van Wichen, D., de Weger, R., Kinzler, K.W., Vogelstein, B., and Clevers, H. (1997). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275, 1784-1787.
26. Lin, S.Y., Xia, W., Wang, J.C., Kwong, K.Y., Spohn, B., Wen, Y., Pestell, R.G., and Hung, M.C. (2000). β-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc. Natl. Acad. Sci. USA 97, 4262-4266.
27. Liu, Z.G., Hsu, H., Goeddel, D.V., and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576.
28. Macleod, K. (1999). pRb and E2f-1 in mouse development and tumorigenesis. Curr. Opin. Genet. Dev. 9, 31-39.
29. Miyagishi, M., Fujii, R., Hatta, M., Yoshida, E., Araya, N., Nagafuchi, A., Ishihara, S., Nakajima, T., and Fukamizu, A. (2000). Regulation of Lef-mediated transcription and p53-dependent pathway by associating β-catenin with CBP/p300. J. Biol. Chem. 275, 35170-35175.
30. Morin, P.J., Sparks, A.B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K.W. (1997). Activation of β-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787-1790.
31. O'Connell, J., Bennett, M.W., Nally, K., Houston, A., O'Sullivan, G.C., and Shanahan, F. (2000). Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict. Ann. N Y Acad. Sci. 910, 178-192; discussion 193-195.
32. Orford, K., Crockett, C., Jensen, J.P., Weissman, A.M., and Byers, S.W. (1997). Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem. 272, 24735-24738.
33. Ouaaz, F., Li, M., and Beg, A.A. (1999). A critical role for the RelA subunit of nuclear factor κB in regulation of multiple immune-response genes and in Fas-induced cell death. J. Exp. Med. 189, 999-1004.
34. Perkins, N.D., Felzien, L.K., Betts, J.C., Leung, K., Beach, D.H., and Nabel, G.J. (1997). Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523-527.
35. Polakis, P. (1999). The oncogenic activation of β-catenin. Curr. Opin. Genet. Dev. 9, 15-21.
36. Polakis, P. (2000). Wnt signaling and cancer. Genes Dev. 14, 1837-1851.
37. Romagnolo, B., Berrebi, D., Saadi-Keddoucci, S., Porteu, A., Pichard, A.L., Peuchmaur, M., Vandewalle, A., Kahn, A., and Perret, C. (1999). Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated β-catenin. Cancer Res. 59, 3875-3879.
38. Ryan, K.M., Ernst, M.K., Rice, N.R., and Vousden, K.H. (2000). Role of NF-κB in p53-mediated programmed cell death. Nature 404, 892-897.
39. Sasaki, T., Irie-Sasaki, J., Horie, Y., Bachmaier, K., Fata, J.E., Li, M., Suzuki, A., Bouchard, D., Ho, A., Redston, M., et al. (2000). Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ. Nature 406, 897-902.
40. Schmid, J.A., Birbach, A., Hofer-Warbinek, R., Pengg, M., Burner, U., Furtmuller, P.G., Binder, B.R., and de Martin, R. (2000). Dynamics of NFκB and IκBα studied with green fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65 binding to DNa by fluorescence resonance energy transfer. J. Biol. Chem. 275, 17035-17042.
41. Sun, Y., Kolligs, F.T., Hottiger, M.O., Mosavin, R., Fearon, E.R., and Nabel, G.J. (2000). Regulation of β-catenin transformation by the p300 transcriptional coactivator. Proc. Natl. Acad. Sci. USA 97, 12613-12618.
42. Tetsu, O., and McCormick, F. (1999). β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426.
43. Trent, J.C., 2nd, McConkey, D.J., Loughlin, S.M., Harbison, M.T., Fernandez, A., and Ananthaswamy, H.N. (1996). Ras signaling in tumor necrosis factor-induced apoptosis. EMBO J. 15, 4497-4505.
44. von Reyher, U., Strater, J., Kittstein, W., Gschwendt, M., Krammer, P.H., and Moller, P. (1998). Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res. 58, 526-534.
45. Wang, C.Y., Mayo, M.W., and Baldwin, A.S., Jr. (1996). TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274, 784-787.
46. Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., and Baldwin, A.S., Jr. (1998). NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and C-IAP1 and c- IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
47. Wang, W., Abbruzzese, J.L., Evans, D.B., Larry, L., Cleary, K.R., and Chiao, P.J. (1999). The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin. Cancer Res. 5, 119-127.
48. Willert, K., and Nusse, R. (1998). β-catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev. 8, 95-102.
49. Wong, M.H., Rubinfeld, B., and Gordon, J.I. (1998). Effects of forced expression of an NH2-terminal truncated β-catenin on mouse intestinal epithelial homeostasis. J. Cell Biol. 141, 765-777.
50. Yang, F., Li, X., Sharma, M., Sasaki, C.Y., Longo, D.L., Lim, B., and Sun, Z. (2002). Linking β-catenin to androgen-signaling pathway. J. Biol. Chem. 277, 11336-11344.
51. Zheng, Y., Ouaaz, F., Bruzzo, P., Singh, V., Gerondakis, S., and Beg, A.A. (2001). NF-κB RelA (p65) is essential for TNF-α-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death. J. Immunol. 166, 4949-4957.
52. Zhou, B.P., Hu, M.C., Miller, S.A., Yu, Z., Xia, W., Lin, S.Y., and Hung, M.C. (2000). HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-κB pathway. J. Biol. Chem. 275, 8027-8031.